PLAUR and breast carcinoma: Expression of an exon 4+5 deleted variant of uPAR has previously been described and was shown to be associated with shorter disease-free survival in breast cancers using a real-time PCR strategy [3], however the assay used did not distinguish between exon 7 variants.